ASP Isotopes Inc. Common Stock

NasdaqCM ASPI

ASP Isotopes Inc. Common Stock Revenue for the Trailing 12 Months (TTM) ending September 30, 2024

ASP Isotopes Inc. Common Stock Revenue is NA for the Trailing 12 Months (TTM) ending September 30, 2024. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • ASP Isotopes Inc. Common Stock Revenue for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 0.00.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
SV Wall Street
NasdaqCM: ASPI

ASP Isotopes Inc. Common Stock

CEO Mr. Paul Elliot Mann C.F.A.
IPO Date Nov. 10, 2022
Location United States
Headquarters 433 Plaza Real
Employees 76
Sector Materials
Industries
Composite Materials Aluminum Chemicals & Advanced Materials Fertilizers Lithium Nuclear Petrochemicals Plastics
Description

ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.

Similar companies

ASIX

AdvanSix Inc.

USD 30.54

-2.37%

StockViz Staff

February 4, 2025

Any question? Send us an email